Loading
Get Ca 19n-2 2015-2026
How it works
-
Open form follow the instructions
-
Easily sign the form with your finger
-
Send filled & signed form or save
How to fill out the CA 19N-2 online
Filling out the CA 19N-2 form is a straightforward process that facilitates the request for a name change. This guide provides a clear step-by-step approach to assist users in completing the form accurately and effectively.
Follow the steps to complete your CA 19N-2 form online.
- Click the ‘Get Form’ button to access the form and open it in your preferred online editor.
- In the first section, provide your personal information. Indicate whether you are a licensee or candidate by checking the respective box. Fill in your last name, suffix (if applicable), first name, middle name, email (optional), home phone, and work phone.
- In the former name section, enter your previous last name, suffix, first name, and middle name as applicable.
- Address of record: Indicate if this is a new address by selecting 'yes' or 'no.' Complete the address fields including your street address, city, state/province, ZIP/postal code, and country. Note that this address will be used for all correspondence and is public information for licensees.
- Make sure to attach a copy of supporting documentation to verify your name change. Acceptable documents may include a copy of a driver's license, passport, marriage license, or court papers.
- Before signing, carefully review all information provided to ensure accuracy. A declaration statement is included, confirming that your representations are true and correct to the best of your knowledge. Ensure that you have not changed your name for fraudulent purposes.
- Sign the form and include the date of signing. Finally, you can save your changes, download a copy, print it, or share the form as needed.
Complete your CA 19N-2 form online today for a smooth name change request process.
Related links form
CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab- plus versus alone in patients with metastatic pancreatic cancer.